P. Jiang

A novel effective therapy for refractory angiosarcoma of the face and scalp.

D. Kantorowitz, P. Jiang, R. Yanke, 2011, Clinical advances in hematology & oncology : H&O.

The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy

H. Deeg, Qiang Yu, A. Ramakrishnan, 2014, PloS one.

Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.

H. Deeg, F. Appelbaum, E. Petersdorf, 2004, Leukemia research.

Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer.

Roman Gulati, C. Higano, E. Yu, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.

Donatello Telesca, Roman Gulati, P. Nelson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

C. Drescher, J. Moon, G. Goodman, 2019, International Journal of Gynecologic Cancer.

Advances in targeted therapy for acute myeloid leukemia

Yingmei Li, Jifeng Yu, Hao Sun, 2020, Biomarker Research.

Advances in targeted therapy for acute myeloid leukemia

Jifeng Yu, Hao Sun, Yongping Song, 2020, Biomarker Research.

Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy

C. Azzoli, K. Kelly, J. R. Pereira, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy

C. Azzoli, K. Kelly, J. R. Pereira, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.